These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9678486

  • 1. Thromboxanes: synthase and receptors.
    Shen RF, Tai HH.
    J Biomed Sci; 1998; 5(3):153-72. PubMed ID: 9678486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Thromboxane A2 receptor; structure, function and tissue distribution].
    Namba T, Narumiya S.
    Nihon Rinsho; 1993 Jan; 51(1):233-40. PubMed ID: 8433523
    [Abstract] [Full Text] [Related]

  • 7. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J, Rolin S, Reynaud D, Qiao N, Kelley LP, Reid HM, Valentin F, Tippins J, Kinsella BT, Masereel B, Pace-Asciak C, Pirotte B, Dogné JM.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane synthase: structure and function of protein and gene.
    Wang LH, Kulmacz RJ.
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():409-22. PubMed ID: 12432933
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor.
    Raychowdhury MK, Yukawa M, Collins LJ, McGrail SH, Kent KC, Ware JA.
    J Biol Chem; 1994 Jul 29; 269(30):19256-61. PubMed ID: 8034687
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
    Lakin KM, Makarov VA, Novikova NV, Tret'iak VM, Rukazenkov IuE.
    Farmakol Toksikol; 1984 Jul 29; 47(2):67-79. PubMed ID: 6425078
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW, Heikes JE, Harris DN, Greenberg R.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Jul 29; 11():337-43. PubMed ID: 6303073
    [No Abstract] [Full Text] [Related]

  • 17. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin.
    Fontana P, Alberts P, Sakariassen KS, Bounameaux H, Meyer JP, Santana Sorensen A.
    J Thromb Haemost; 2011 Oct 29; 9(10):2109-11. PubMed ID: 21777369
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD, Hamilton JG.
    Adv Prostaglandin Thromboxane Res; 1980 Oct 29; 6():453-6. PubMed ID: 6770605
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.